Centene EBITDA 2012-2026 | CNC

Centene EBITDA for the quarter ending March 31, 2026 was $-6.637B, a 778.63% decline year-over-year.

  • Centene 2024 EBITDA was 4.416B, a 4.57% increase from 2023.
  • Centene 2023 EBITDA was 4.223B, a 53.68% increase from 2022.
  • Centene 2022 EBITDA was 2.748B, a 11.89% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Centene EBITDA 2012-2026 | CNC

  • Centene 2024 EBITDA was 4.416B, a 4.57% increase from 2023.
  • Centene 2023 EBITDA was 4.223B, a 53.68% increase from 2022.
  • Centene 2022 EBITDA was 2.748B, a 11.89% decline from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
UnitedHealth Group (UNH)$276.2B
Cigna Group (CI)$71.5B
Humana (HUM)$23.1B
Molina Healthcare (MOH)$7.6B
Select Medical Holdings (SEM)$2B
Joint (JYNT)$125M
Aethlon Medical (AEMD)$3M